bradykinin, leu(8)-des-arg(9)- has been researched along with Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, M; Inoue, N; Kobayashi, K; Kondo, T; Li, P; Murohara, T; Numaguchi, Y; Okumura, K | 1 |
| Bader, M; Bonaria Salis, M; Cayla, C; Emanueli, C; Gaspa, L; Isner, JM; Kirchmair, R; Madeddu, P; Pesquero, JB; Pinna, A; Pintus, G; Regoli, D; Stacca, T | 1 |
2 other study(ies) available for bradykinin, leu(8)-des-arg(9)- and Ischemia
| Article | Year |
|---|---|
Role of bradykinin, nitric oxide, and angiotensin II type 2 receptor in imidapril-induced angiogenesis.
Topics: Angiogenesis Inducing Agents; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Capillaries; Enzyme Inhibitors; Hindlimb; Imidazoles; Imidazolidines; Ischemia; Male; Mice; Mice, Knockout; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2008 |
Targeting kinin B(1) receptor for therapeutic neovascularization.
Topics: Animals; Apoptosis; Bradykinin; Bradykinin Receptor Antagonists; Cell Division; Cells, Cultured; Endothelium, Vascular; Extremities; Humans; Ischemia; Laser-Doppler Flowmetry; Mice; Mice, Knockout; Muscle, Skeletal; Neovascularization, Physiologic; Perfusion; Receptor, Bradykinin B1; Receptors, Bradykinin; Signal Transduction | 2002 |